To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years.
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up / Wiemer, M., Stoikovic, S., Samol, A., Dimitriadis, Z., Ruiz-Nodar, J.M., Birkemeyer, R., Monsegu, J., Finet, G., Hildick-Smith, D., Tresukosol, D., Novo, E.G., Koolen, J.J., Barbato, E., Danzi, G.B.. - In: CARDIOVASCULAR DIABETOLOGY. - ISSN 1475-2840. - 16:1(2017), p. 23. [10.1186/s12933-017-0500-3]
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
Barbato, EmanueleMembro del Collaboration Group
;
2017
Abstract
To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
